Medico Remedies Profit & Loss Annual

BSE: 540937 | NSE: MEDICO | ISIN: INE630Y01024 | Sector: Biotechnology & Drugs

47.19 +1.70 (3.74%)Updated : 12 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	192.44	138.97	134.89	133.54
Other Net	5.93	-0.89	-0.51	-0.50
Diluted Weighted Average Shares	8.30	8.30	8.30	8.30
Depreciation/ Amortization	3.09	3.03	2.88	2.72
Operating Income	13.93	11.97	10.03	6.90
Net Income	13.12	10.09	8.29	7.24
Income Availableto Com Excl Extra Ord	13.12	10.09	8.29	7.24
Net Income Before Taxes	18.06	13.50	11.33	10.10
Other Operating Expenses Total	30.62	-	16.18	20.19
Net Income After Taxes	13.12	10.09	8.29	7.24
Income Availableto Com Incl Extra Ord	13.12	10.09	8.29	7.24
Costof Revenue Total	151.33	119.08	109.91	104.87
Gross Profit	55.05	31.86	35.01	35.57
Interest Inc( Exp) Net- Non- Op Total	-1.81	2.42	1.82	3.70
Diluted Net Income	13.12	10.09	8.29	7.24
Provisionfor Income Taxes	4.94	3.41	3.04	2.86
period Type	-	-	-	-
Net Income Before Extra Items	13.12	10.09	8.29	7.24
Total Revenue	206.38	150.94	144.92	140.44
period Length	12.00	12.00	12.00	12.00
Revenue	206.38	150.94	144.92	140.44
Selling/ General/ Admin Expenses Total	7.40	16.85	5.92	5.75
Diluted Normalized EPS	1.58	1.22	1.00	0.87
Diluted EPS Excluding Extra Ord Items	1.58	1.22	1.00	0.87

*All figures in crores except per share values

Trending Stocks

5,098.20+155.20(3.14%)

1,102.85+20.85(1.93%)

2,024.95+23.05(1.15%)

1,072.00-24.05 (-2.19%)

310.50-4.95 (-1.57%)

Related News